Pharmos(PARS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Pharmos(PARS)

PARS 2.700

+13.6%

Jan 21 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Ariella who wrote (1248)	9/17/1998 5:23:00 PM
From: Richard Huth	of 1491

Dear Ariella Thank you for your comprehensive report. I think you are right by saying PARS offers a good risk/reward ratio, but we should not expect too much within the next months - todays drop seems to reflect the reduced optimism about an assumed strong reaction on possible positive news about HU211. Actually the market in general (at least for biotech comp.) does look more on positive phase III data and earnings, so unblinding of HU211 might be without any positive effect on stock prices in the short run. Therefore I also agree with you that most important for PARS is finding new partners to reverse the downside trend or PARS. -- the niche audience that PARS needs to attract is investors who are knowledgeable about pharmaceuticals and biotechs, not folks searching for that 10-bagger in any industry simply because the stock is currently priced under $5. How about if we start a new thread under the pharmaceutical/ biotech section in SI? -- I only can support your proposal - but why not move the complete thread? -Richard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next